01/30/2020 12:00 AM EST
Source: World Health Organization (WHO). Published: 1/30/2020. This web page provides information about the second meeting of the Emergency Committee convened by the World Health Organization (WHO) Director-General under the International Health Regulations (IHR) (2005) on January 30, 2020, regarding the outbreak of novel coronavirus 2019-nCoV in the People’s Republic of China. The Director-General declared that the outbreak of 2019-nCoV constitutes a Public Health Emergency of International Concern (PHEIC), accepted the Committee’s advice, and issued this advice as Temporary Recommendations under the IHR (2005). It is expected that further international exportation of cases may appear in any country. Thus, all countries should be prepared for containment, including active surveillance, early detection, isolation and case management, contact tracing, and prevention of onward spread of 2019-nCoV infection, and to share full data with WHO. (Text)
01/30/2020 12:00 AM EST
Source: Centers for Disease Control and Prevention, Office of Infectious Diseases (CDC OID). Published: 1/30/2020. This web page provides answers to frequently asked questions about the 2019 Novel Coronavirus, or 2019-nCoV. Topics cover Disease Basics, Prevention, Medical Information, Public Health Response and Current Situation, Travel, and 2019-nCoV and Animals. It also provides links to additional information on each topic. (Text)
01/30/2020 12:00 AM EST
Source: European Union, European Centre for Disease Prevention and Control (ECDC). Published: 1/30/2020. This four-page document aims to provide guidance for European Union/European Economic Area (EU/EEA) public health authorities on the management of persons having had contact with novel coronavirus cases. It is intended for public health professionals and healthcare practitioners. The purpose of managing 2019-nCoV case contacts is to identify symptomatic contacts as early as possible for isolation and treatment, and to facilitate prompt laboratory diagnostic testing. (PDF)
01/30/2020 12:00 AM EST
Source: European Union, European Centre for Disease Prevention and Control (ECDC). Published: 1/30/2020. This algorithm shows the main actions for contacts of probable or confirmed 2019-nCoV cases. Implementation may be modified depending on the risk assessment for individual cases and their contacts by public health authorities. (Text)
01/29/2020 12:00 AM EST
Source: Centers for Disease Control and Prevention, Office of Infectious Diseases (CDC OID). Published: 1/29/2020. This interim guidance is based on what is currently known about 2019 novel coronavirus (2019-nCoV) and transmission of other viral respiratory infections. It is for people confirmed to have 2019-nCoV infection, who do not need to be hospitalized and who can receive care at home; people being evaluated by a healthcare provider for 2019-nCoV infection, who do not need to be hospitalized and who can receive care at home; caregivers and household members of a person confirmed to have, or being evaluated for, 2019-nCoV infection; and other people who have had close contact with a person confirmed to have, or being evaluated for, 2019-nCoV infection. (Text)
01/28/2020 12:00 AM EST
Source: Centers for Disease Control and Prevention, Office of Infectious Diseases (CDC OID). Published: 1/28/2020. This guidance, updated on January 28, 2020, is based on the currently limited information available about 2019-nCoV related to disease severity, transmission efficiency, and shedding duration. This cautious approach will be refined and updated as more information becomes available and as response needs change in the United States. This guidance is applicable to all U.S. healthcare settings. This guidance is not intended for non-healthcare settings (e.g., schools) or to persons outside of healthcare settings. (Text)
01/28/2020 12:00 AM EST
Source: Center for Health Security [Johns Hopkins University, Bloomberg School of Public Health]. Published: 1/28/2020. This two-page fact sheet provides information about the World Health Organization (WHO) and its primary responsibility to respond to natural disasters and disease outbreaks. Priorities include supporting countries in building their national capacities; advocating for preparedness; developing strategies and global response plans for health emergencies; and providing operational response activities. A WHO Emergency Committee has convened to discuss the outbreak of novel coronavirus (2019-nCoV). (PDF)
01/27/2020 12:00 AM EST
Source: Centers for Disease Control and Prevention, Office of Infectious Diseases (CDC OID). Published: 1/27/2020. This resource describes the use of real-time RT PCR (rT-PCR) assays for the in vitro qualitative detection of 2019-Novel Coronavirus (2019-nCoV) in respiratory specimens and sera. The 2019-nCoV primer and probe sets are designed for the universal detection of SARS-like coronaviruses and for specific detection of 2019-nCoV. Sections cover Specimens; Reagents, Supplies, and Equipment Requirements; Nucleic Acid Extraction; Quality Control; rRT-PCR Assays; Interpreting Test Results; Assay Limitations; and Contact Information. (Text)
01/27/2020 12:00 AM EST
Source: Center for Health Security [Johns Hopkins University, Bloomberg School of Public Health]. Published: 1/27/2020. This one-page document provides a summary of findings from the latest phylogenetic research on 2019-nCoV. Key findings are that a PCR diagnostic test can differentiate 2019-nCoV from other coronaviruses; the outbreak was initiated from either a single introduction into humans or very few animal-to-human transmission events; and nCoV-2019 and SARS-CoV use the same cellular receptor, ACE2, which could be used as a starting point for creating therapeutics for nCoV-2019. (PDF)
01/26/2020 12:00 AM EST
Source: Center for Health Security [Johns Hopkins University, Bloomberg School of Public Health]. Published: 1/26/2020. This one-page fact sheet provides information about several major sources of money that could be used to support outbreak response activities, including the Pandemic Emergency Financing Facility, which could be used in a coronavirus pandemic; World Bank’s International Development Association Crisis Response Window; International Monetary Fund; national governments; and private charity. (PDF)
01/25/2020 12:00 AM EST
Source: Centers for Disease Control and Prevention, Office of Infectious Diseases (CDC OID). Published: 1/25/2020. This web page provides a table of procedures and/or reagents derived thereof that are intended to be used for the purposes of respiratory virus surveillance and research. They are intended for public health surveillance and evaluation purposes. (Text)
01/21/2020 12:00 AM EST
Source: Centers for Disease Control and Prevention (CDC). Published: 1/21/2020. This one-hour session of Public Health Grand Rounds addresses the rapid advances in Advanced Molecular Detection (AMD), how these technologies are being applied in public health, and their future uses. The principal objectives of AMD include improving pathogen detection and characterization, and enabling new diagnostic methods to meet public health needs. AMD technologies are now in use across the range of infectious diseases of public health importance, such as bacterial foodborne illness, tuberculosis, influenza, malaria, and Legionnaires’ Disease. (Video or Multimedia)
01/13/2020 12:00 AM EST
Source: National Academies of Sciences, Engineering, and Medicine. Published: 1/13/2020. Despite ample evidence to support the need for personal protective equipment for all health care workers, a 2019 National Academies of Sciences, Engineering, and Medicine report suggests that a sizable number of health care workers may be inadequately protected from airborne transmissible diseases. This resource reviews findings from that report, and proposes four strategies to protect health care workers from airborne transmissible diseases. (Text)
01/01/2020 12:00 AM EST
Source: European Union, European Centre for Disease Prevention and Control (ECDC). Published: 1/2020. This five-page report on cases of yersiniosis is based on data for 2017 retrieved from The European Surveillance System (TESSy) on September 11, 2018. For 2017, 28 countries reported 6,890 confirmed yersiniosis cases in the European Union/European Economic Area. The highest rates were reported by Finland, Lithuania, and the Czech Republic. (PDF)
.png)
No hay comentarios:
Publicar un comentario